13F HOLDINGS REPORT
Ghost Tree Capital, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001420506-24-002434
Total Value
$331.0M
Positions
54
Other Managers
0
Confidential Omitted
No
Holdings (54)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 300,000 | $29.6M | 8.95% |
| 2 | BIOHAVEN LTD | BHVN | 348,778 | $17.4M | 5.26% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 120,000 | $15.0M | 4.53% |
| 4 | NOVO-NORDISK A S | NONOF | 110,000 | $13.1M | 3.96% |
| 5 | BLUEPRINT MEDICINES CORP | 09627Y109 | 140,000 | $12.9M | 3.91% |
| 6 | AXSOME THERAPEUTICS INC | AXSM | 135,000 | $12.1M | 3.66% |
| 7 | TARSUS PHARMACEUTICALS INC | TARS | 350,000 | $11.5M | 3.48% |
| 8 | PERSPECTIVE THERAPEUTICS INC | CATX | 750,000 | $10.0M | 3.02% |
| 9 | CG ONCOLOGY INC | CGON | 250,000 | $9.4M | 2.85% |
| 10 | ROIVANT SCIENCES LTD | ROIV | 800,000 | $9.2M | 2.79% |
| 11 | VAXCYTE INC | PCVX | 80,000 | $9.1M | 2.76% |
| 12 | VIKING THERAPEUTICS INC | VKTX | 140,000 | $8.9M | 2.68% |
| 13 | SYNDAX PHARMACEUTICALS INC | SNDX | 450,000 | $8.7M | 2.62% |
| 14 | JANUX THERAPEUTICS INC | JANX | 190,000 | $8.6M | 2.61% |
| 15 | ASCENDIS PHARMA A/S | ASND | 52,500 | $7.8M | 2.37% |
| 16 | CRINETICS PHARMACEUTICALS IN | CRNX | 150,000 | $7.7M | 2.32% |
| 17 | SOLENO THERAPEUTICS INC | SLNO | 150,000 | $7.6M | 2.29% |
| 18 | TG THERAPEUTICS INC | TGTX | 310,000 | $7.3M | 2.19% |
| 19 | REZOLUTE INC | RZLT | 1,474,995 | $7.2M | 2.16% |
| 20 | PHATHOM PHARMACEUTICALS INC | PHAT | 375,000 | $6.8M | 2.05% |
| 21 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 128,411 | $6.5M | 1.96% |
| 22 | OLEMA PHARMACEUTICALS INC | OLMA | 535,000 | $6.4M | 1.93% |
| 23 | IMMUNOVANT INC | IMVT | 215,000 | $6.1M | 1.85% |
| 24 | INSMED INC | INSM | 75,000 | $5.5M | 1.65% |
| 25 | EDGEWISE THERAPEUTICS INC | EWTX | 195,000 | $5.2M | 1.57% |
| 26 | REPLIMUNE GROUP INC | REPL | 450,000 | $4.9M | 1.49% |
| 27 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 220,000 | $4.5M | 1.37% |
| 28 | BRIDGEBIO PHARMA INC | BBIO | 175,000 | $4.5M | 1.35% |
| 29 | TAYSHA GENE THERAPIES INC | TSHA | 2,150,000 | $4.3M | 1.31% |
| 30 | RHYTHM PHARMACEUTICALS INC | RYTM | 78,842 | $4.1M | 1.25% |
| 31 | ANNEXON INC | ANNX | 650,000 | $3.8M | 1.16% |
| 32 | KORRO BIO INC | KRRO | 110,000 | $3.7M | 1.11% |
| 33 | INSMED INC | INSM | 50,000 | $3.6M | 1.10% |
| 34 | DYNE THERAPEUTICS INC | DYN | 100,000 | $3.6M | 1.09% |
| 35 | ARVINAS INC | ARVN | 145,000 | $3.6M | 1.08% |
| 36 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 160,000 | $3.3M | 1.00% |
| 37 | HELIX ACQUISITION CORP II | HLXC | 300,000 | $3.1M | 0.95% |
| 38 | NUVATION BIO INC | NUVB | 1,350,000 | $3.1M | 0.93% |
| 39 | SAVARA INC | SVRA | 725,000 | $3.1M | 0.93% |
| 40 | TENAYA THERAPEUTICS INC | TNYA | 1,500,000 | $2.9M | 0.87% |
| 41 | REGENXBIO INC | RGNX | 265,000 | $2.8M | 0.84% |
| 42 | CORVUS PHARMACEUTICALS INC | CRVS | 500,000 | $2.6M | 0.80% |
| 43 | ABSCI CORPORATION | ABSI | 550,000 | $2.1M | 0.63% |
| 44 | NEUROGENE INC | NGNE | 50,000 | $2.1M | 0.63% |
| 45 | CAPRICOR THERAPEUTICS INC | CAPR | 125,000 | $1.9M | 0.57% |
| 46 | APELLIS PHARMACEUTICALS INC | APLS | 65,000 | $1.9M | 0.57% |
| 47 | SUMMIT THERAPEUTICS INC | SMMT | 85,000 | $1.9M | 0.56% |
| 48 | SPYRE THERAPEUTICS INC | SYRE | 60,000 | $1.8M | 0.53% |
| 49 | VIRIDIAN THERAPEUTICS INC | VRDN | 75,000 | $1.7M | 0.52% |
| 50 | PROQR THRAPEUTICS N V | N71542109 | 887,700 | $1.6M | 0.49% |
| 51 | ATYR PHARMA INC | ATYR | 800,000 | $1.4M | 0.43% |
| 52 | LARIMAR THERAPEUTICS INC | LRMR | 200,000 | $1.3M | 0.40% |
| 53 | ENGENE HOLDINGS INC | ENGNW | 160,898 | $1.1M | 0.32% |
| 54 | AMYLYX PHARMACEUTICALS INC | AMLX | 325,000 | $1.1M | 0.32% |